Top 5 Stocks to Buy Now
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free IBB Stock Alerts

iShares Biotechnology ETF (IBB) Short Interest Ratio & Short Volume

iShares Biotechnology ETF logo
$173.64 0.00 (0.00%)
As of 06/18/2026 04:00 PM Eastern
Compare

iShares Biotechnology ETF Short Interest Overview

As of May 29, 2026, iShares Biotechnology ETF (IBB) had a short interest of 13.24 million shares sold short, representing 27.88% of the public float. This marks a 1.80% increase in short interest since the prior report. The short interest ratio (days to cover) is 8.8, meaning it would take 8.8 days of the average trading volume of 1.24 million shares to cover all short positions.

Current Short Interest
13,243,596 shares
Previous Short Interest
13,009,363 shares
Change Vs. Previous Month
1.80%
Dollar Volume Sold Short
$2.28 billion
Short Interest Ratio
8.8 Days to Cover
Last Record Date
May 29, 2026
Outstanding Shares
47,500,000 shares
Short Percent of Float
27.88%
Today's Trading Volume
985,208 shares
Average Trading Volume
1,240,201 shares
Today's Volume Vs. Average
79%
Short Selling iShares Biotechnology ETF?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for iShares Biotechnology ETF and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

IBB Short Interest Over Time

IBB Days to Cover Over Time

IBB Percentage of Float Shorted Over Time

iShares Biotechnology ETF Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/29/202613,243,596 shares $2.28 billion +1.8%27.9%8.78 $172.18
5/15/202613,009,363 shares $2.17 billion -1.9%27.8%9.67 $166.83
4/30/202613,267,269 shares $2.24 billion +5.4%28.2%9.08 $168.69
4/15/202612,584,040 shares $2.21 billion -5.4%26.5%9.39 $175.99
3/31/202613,298,650 shares $2.25 billion -7.1%27.7%7.84 $168.85
3/13/202614,315,391 shares $2.37 billion -3.9%29.4%7.65 $165.51
2/27/202614,892,958 shares $2.61 billion -1.1%30.1%9.32 $175.37
2/13/202615,059,984 shares $2.60 billion +18.4%30.7%6.94 $172.57
1/30/202612,721,468 shares $2.19 billion +0.2%25.8%7.48 $172.43
1/15/202612,700,561 shares $2.17 billion +0.8%25.7%6.17 $170.56
12/31/202512,595,742 shares $2.13 billion -5.9%25.2%8.52 $168.77
12/15/202513,378,601 shares $2.27 billion +9.5%26.8%8.09 $169.38
11/28/202512,218,668 shares $2.12 billion -1.2%24.2%4.09 $173.63
11/14/202512,364,326 shares $2.03 billion +4.8%25.1%4.81 $164.19
10/31/202511,794,089 shares $1.88 billion +0.8%27.4%6.03 $159.38
10/15/202511,700,000 shares $1.79 billion -6.8%28.1%6.4 $153.39
9/30/202512,550,000 shares $1.81 billion +15.9%N/A7.4 $144.37
9/15/202510,830,000 shares $1.52 billion +3.8%N/A6.8 $140.72
8/31/202510,430,000 shares $1.44 billion No Change25.9%6.3 $138.22
5/15/202512,860,000 shares $1.53 billion +15.7%29.4%7.7 $119.24
4/30/202511,120,000 shares $1.41 billion +6.8%N/A6.9 $126.58
4/15/202510,410,000 shares $1.25 billion +7.1%23.6%7.1 $119.85
3/31/20259,720,000 shares $1.24 billion -1.0%21.2%6.7 $127.90
3/15/20259,820,000 shares $1.32 billion +4.8%20.8%7.4 $134.19
2/28/20259,370,000 shares $1.28 billion +2.5%19.8%6.7 $137.03
2/15/20259,140,000 shares $1.25 billion -9.4%19.3%6.4 $136.55
1/31/202510,090,000 shares $1.40 billion -9.2%N/A6.7 $138.66
1/15/202511,110,000 shares $1.48 billion -1.1%N/A7.7 $133.42
12/31/202411,230,000 shares $1.48 billion -3.8%N/A8.4 $132.21
12/15/202411,670,000 shares $1.59 billion +3.6%N/A9 $136.61
11/30/202411,260,000 shares $1.59 billion +9.5%N/A9.1 $141.55
11/15/202410,280,000 shares $1.37 billion +1.4%N/A8.6 $133.38
10/31/202410,140,000 shares $1.42 billion +3.3%N/A9.8 $140.29
10/15/20249,820,000 shares $1.43 billion +1.5%N/A8.8 $145.82
9/30/20249,680,000 shares $1.41 billion +4.1%N/A8 $145.60
9/15/20249,300,000 shares $1.37 billion -8.6%N/A7.4 $147.81
8/31/202410,180,000 shares $1.51 billion +0.4%N/A8.3 $148.17
8/15/202410,140,000 shares $1.47 billion -7.2%N/A7.7 $144.95
7/31/202410,930,000 shares $1.62 billion -10.5%N/A8 $147.97
7/15/202412,210,000 shares $1.77 billion No ChangeN/A8.7 $145.15
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
1/15/20248,740,000 shares $1.20 billion +4.3%N/A4.6 $137.13
12/31/20238,380,000 shares $1.14 billion -14.1%N/A4.2 $135.85
12/15/20239,760,000 shares $1.29 billion -8.9%N/A4.7 $131.78
11/30/202310,710,000 shares $1.30 billion +5.6%N/A5.5 $120.93
11/15/202310,140,000 shares $1.20 billion -3.9%N/A5.2 $118.03
10/31/202310,550,000 shares $1.20 billion +6.5%N/A5.7 $113.68
10/15/20239,910,000 shares $1.21 billion -2.5%N/A6 $121.63
9/30/202310,160,000 shares $1.24 billion +7.7%N/A6.7 $122.29
9/15/20239,430,000 shares $1.19 billion -7.0%N/A6.6 $126.61
8/31/202310,140,000 shares $1.31 billion -0.4%N/A6.6 $128.71
8/15/202310,180,000 shares $1.30 billion +1.9%N/A6.6 $128.01
7/31/20239,990,000 shares $1.29 billion +2.7%N/A6.3 $129.31
7/15/20239,730,000 shares $1.25 billion -7.3%N/A6 $128.24
6/30/202310,500,000 shares $1.33 billion +0.4%N/A6.5 $126.96
6/15/202310,460,000 shares $1.38 billion +10.2%N/A6.7 $131.81
5/31/20239,490,000 shares $1.20 billion +1.3%N/A6 $126.28
5/15/20239,370,000 shares $1.23 billion -6.4%N/A6 $131.74
4/30/202310,010,000 shares $1.31 billion +2.5%N/A6.4 $130.51
4/15/20239,770,000 shares $1.29 billion -0.8%N/A6.3 $132.43
3/31/20239,850,000 shares $1.27 billion -6.5%N/A6.4 $129.16
3/15/202310,530,000 shares $1.33 billion +12.4%N/A6.7 $126.06
2/28/20239,370,000 shares $1.19 billion -7.0%N/A6.2 $127.18
2/15/202310,070,000 shares $1.35 billion +6.7%N/A6.4 $133.77
1/31/20239,440,000 shares $1.29 billion -4.4%N/A5.6 $136.55
1/15/20239,870,000 shares $1.34 billion -5.5%N/A5.6 $136.23
12/30/202210,440,000 shares $1.37 billion +4.7%N/A5.7 $131.29
12/15/20229,970,000 shares $1.34 billion -8.8%N/A5.2 $134.24
11/30/202210,930,000 shares $1.49 billion +5.0%N/A5.5 $136.53
11/15/202210,410,000 shares $1.41 billion +6.9%N/A5.3 $135.11
10/31/20229,740,000 shares $1.25 billion -15.4%N/A5.1 $128.59
10/15/202211,510,000 shares $1.38 billion No ChangeN/A6.2 $119.58
9/30/20229,180,000 shares $1.07 billion +16.8%N/A4.9 $116.96
9/15/20227,860,000 shares $975.03 million +12.8%N/A4.1 $124.05
8/31/20226,970,000 shares $846.58 million -19.6%N/A3.5 $121.46
8/15/20228,670,000 shares $1.17 billion +14.4%N/A4.3 $134.82
7/31/20227,580,000 shares $940.53 million -2.3%N/A3.2 $124.08
7/15/20227,760,000 shares $956.42 million -12.7%N/A3 $123.25
6/30/20228,890,000 shares $1.05 billion +1.1%N/A3.3 $117.63
6/15/20228,790,000 shares $955.12 million +12.7%N/A3.2 $108.66
5/31/20227,800,000 shares $910.03 million -6.0%N/A2.9 $116.67
5/15/20228,300,000 shares $939.06 million +3.2%N/A3 $113.14
4/30/20228,040,000 shares $937.87 million -6.9%N/A3 $116.65
4/15/20228,640,000 shares $1.13 billion -9.5%N/A3.2 $130.86
3/31/20229,550,000 shares $1.24 billion -20.2%N/A3.5 $130.30
3/15/202211,970,000 shares $1.45 billion +6.2%N/A4.4 $121.13
2/28/202211,270,000 shares $1.42 billion +10.5%N/A4.1 $126.07
2/15/202210,200,000 shares $1.33 billion -4.5%N/A3.6 $129.98
1/31/202210,680,000 shares $1.41 billion +4.3%N/A4 $131.86
1/15/202210,240,000 shares $1.42 billion +9.6%N/A4.1 $138.95
12/31/20219,340,000 shares $1.43 billion -9.3%N/A4.3 $152.62
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel

Get the name and ticker of Louis Navellier's #1 AI stock free
12/15/202110,300,000 shares $1.56 billion -1.4%N/A4.7 $151.90
11/30/202110,450,000 shares $1.61 billion -11.3%N/A5 $154.22
11/15/202111,780,000 shares $1.80 billion +6.9%N/A6 $153.18
10/29/202111,020,000 shares $1.76 billion -0.1%N/A5.2 $159.60
10/15/202111,030,000 shares $1.73 billion -14.6%N/A4.9 $157.06
9/30/202112,920,000 shares $2.09 billion +10.6%N/A5.1 $161.68
9/15/202111,680,000 shares $2.01 billion +1.9%N/A4.6 $171.80
8/31/202111,460,000 shares $1.97 billion +0.5%N/A4.3 $172.28
8/13/202111,400,000 shares $1.93 billion -12.6%N/A3.7 $169.40
7/30/202113,050,000 shares $2.16 billion -5.8%N/A4 $165.78
7/15/202113,860,000 shares $2.21 billion -4.6%N/A4.1 $159.25
6/30/202114,520,000 shares $2.38 billion -1.9%N/A4.3 $163.65

IBB Short Interest - Frequently Asked Questions

Short interest is the volume of iShares Biotechnology ETF shares that have been sold short but have not yet been closed out or covered. As of May 29th, traders have sold 13,243,596 shares of IBB short. 27.88% of iShares Biotechnology ETF's shares are currently sold short. Learn More on iShares Biotechnology ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IBB shares currently have a short interest ratio of 8.8. Learn More on iShares Biotechnology ETF's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 27.88% of iShares Biotechnology ETF's floating shares are currently sold short.

iShares Biotechnology ETF saw a increase in short interest in May. As of May 29th, there was short interest totaling 13,243,596 shares, an increase of 1.8% from the previous total of 13,009,363 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

27.88% of iShares Biotechnology ETF's shares are currently sold short. Here is how the short interest of companies compare to iShares Biotechnology ETF: VanEck Pharmaceutical ETF (12.75%), VanEck Biotech ETF (0.34%), Invesco S&P SmallCap Health Care ETF (0.89%), Invesco Dorsey Wright Healthcare Momentum ETF (0.11%), F/m Emerald Life Sciences Innovation ETF (0.15%), ProShares Ultra Nasdaq Biotechnology (0.52%), Invesco Nasdaq Biotechnology ETF (0.86%), First Trust Nasdaq Pharmaceuticals ETF (2.19%), Global X HealthTech ETF (0.54%), T. Rowe Price Health Care ETF (1.29%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($81.27 billion), Invesco QQQ ($49.06 billion), iShares Russell 2000 ETF ($23.61 billion), Western Digital Corporation ($16.93 billion), Sandisk Corporation ($15.61 billion), Salesforce Inc. ($11.65 billion), SPDR S&P Biotech ETF ($10.52 billion), Nebius Group N.V. ($10.24 billion), Lumentum Holdings Inc. ($8.74 billion), and iShares iBoxx $ High Yield Corporate Bond ETF ($8.21 billion). View all of the most shorted stocks.

Short selling IBB is an investing strategy that aims to generate trading profit from iShares Biotechnology ETF as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for iShares Biotechnology ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IBB, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IBB, twice per month. The most recent reporting period available is May, 29 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like IBB:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:IBB) was last updated on 6/9/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
A huge SpaceX error just led one stock to 3X move!
SPCE surged roughly 300% in a single week after investors hunting SpaceX exposure piled into the wrong ticker....
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel